High Frequency of Polymicrobial Infections After Surgical Resection of Malignant Bone and Soft Tissue Tumors: A Retrospective Cohort Study
Related Experiment Video
Updated: Apr 4, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
Laura M Vos1,2, Philippe C Morand3,4, David Biau4,5
1Infectious and Tropical Medicine, Internal Medicine Department, Cochin Hospital APHP, Paris, France.
Introduction:
Surgical resection of a malignant bone tumor (BT) or soft tissue tumor (STT), with or without prosthetic replacement, carries a high risk of developing postoperative infections. There is limited knowledge on the bacteriological spectrum of these postsurgical infections that necessitate empirical antibiotic therapy. The aim of this study was to analyze the incidence and microbiological features of site infections following BT or STT resection.
Methods:
In this retrospective mono-center study, we analyzed the surgical and bacteriological data of all consecutive patients who developed an infection after surgical resection of a BT or STT between January 2010 and April 2014.
Results:
Seventy-two consecutive patients who developed an infection on the site of surgical treatment for a BT (n = 42) or SST (n = 30) were included. Polymicrobism was frequently observed, more often associated with STTs (93%) than BTs (71%; P = 0.03). Gram-negative bacteria were more frequently isolated in STTs (55%) than in BTs (26%; P = 0.01) and non-prosthesis-associated infections (54%) than prosthesis-associated infections (29%; P = 0.04), whereas staphylococci were more frequently found in BTs (76%) than in STTs (52%; P = 0.03). Overall, we found gram negatives in 82% of early acute infections, 11% of chronic infections and 7% of late acute infections (P < 0.01).
Conclusion:
Postoperative infections in patients after surgical resection of BTs or STTs were often polymicrobial, especially following STTs. Causative bacteria were often gram negatives in STTs and non-prosthesis-associated infections, whereas staphylococci were predominant in BTs. Based on these findings, we recommend antibiotic coverage of both gram-positive and -negative bacteria with a combination of broad-spectrum antibiotics in STTs and antistaphylococcal antibiotics as first-line therapy in infections following BT surgery.
Insights
Postoperative infections after bone tumor (BT) or soft tissue tumor (STT) surgery are often polymicrobial. Antibiotic therapy should target gram-positive and gram-negative bacteria, with specific considerations for BT versus STT infections.
Area of Science:
- Oncology
- Infectious Diseases
- Surgical Pathology
Background:
- Surgical resection of bone tumors (BT) and soft tissue tumors (STT) carries a significant risk of postoperative infections.
- Limited data exists on the specific bacteriological profiles of these infections, impacting empirical antibiotic choices.
Purpose of the Study:
- To analyze the incidence and microbiological characteristics of site infections following BT or STT resection.
- To inform empirical antibiotic therapy strategies for postsurgical infections.
Main Methods:
- Retrospective, single-center study analyzing surgical and bacteriological data.
- Inclusion of consecutive patients who developed infections after BT or STT resection between January 2010 and April 2014.
Main Results:
- 72 infections were analyzed (42 BT, 30 STT).
- Polymicrobial infections were common, especially in STTs (93%) vs. BTs (71%).
- Gram-negative bacteria were more prevalent in STTs (55%) and non-prosthesis infections (54%), while staphylococci predominated in BTs (76%). Gram-negatives were frequent in early acute infections (82%).
Conclusions:
- Postoperative infections after BT/STT resection are frequently polymicrobial, particularly after STT surgery.
- Bacteriological patterns differ: gram-negatives in STTs, staphylococci in BTs.
- Recommended empirical antibiotic therapy should include broad-spectrum coverage for STTs and antistaphylococcal agents for BTs.
More Related Videos
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
06:53Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020